BioRender Icon

Endothelial cell 1 (dying 2)

Endothelial cell 1 (dying 2) - Editable icon of a dying flat, rectangular endothelial cell with a domed nucleus
[{"image":"https://icons.cdn.biorender.com/w75xh75/636524346b73320021b58769/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524346b73320021b58769/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524346b73320021b58768/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524346b73320021b58768/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5879b/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5879b/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5879a/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5879a/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58799/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58799/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58798/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58798/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58797/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58797/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58796/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58796/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58795/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58795/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58794/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58794/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58793/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58793/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58792/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58792/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58791/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58791/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58790/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58790/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5878f/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5878f/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5878e/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5878e/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5878d/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5878d/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5878c/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5878c/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5878b/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5878b/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5878a/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5878a/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58789/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58789/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58788/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58788/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58787/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58787/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58786/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58786/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58785/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58785/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58784/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58784/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58783/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58783/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58782/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58782/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58781/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58781/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58780/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58780/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5877f/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5877f/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5877e/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5877e/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5877d/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5877d/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5877c/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5877c/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5877b/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5877b/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5877a/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5877a/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58779/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58779/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58778/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58778/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58777/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58777/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58776/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58776/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58775/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58775/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58774/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58774/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58773/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58773/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58772/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58772/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58771/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58771/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58770/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58770/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5876f/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5876f/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5876e/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5876e/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5876d/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5876d/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5876c/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5876c/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5876b/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5876b/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5876a/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5876a/63628e6f99665a0021bbba2b.png"}]
Use This Icon – Free
No credit card required to sign up.

This icon is fully editable in BioRender

  • Add text, shapes, & other icons
  • Search 50,000+ scientifically accurate icons
  • Recolor and rearrange every icon, line, & label
  • Export or share for any use case
Scientist Avatars

Join 4M+ scientists already making publication-ready figures

Go from icons to finished figure – in minutes

  • Search from 50,000+ scientifically accurate, peer-reviewed icons
  • Customize with labels, shapes, and additional icons – everything is completely editable
  • Export or share your figures with collaborators

Not quite the right icon? Discover more.

Search 50,000+ icons across 30+ life-science fields.

search icon
arrow-right
Keywords
endothelial,endothelium,endothelia,blood vessel,vessel,capillary,alveolar,BBB,leaky BBB,blood,lymphatic,lymphatic vessel,circulatory,cardiovascular,circulatory system,cardiovascular system,blood brain barrier,dying,dead,degrade,degradation,die,compromised,necrosis,necrotic,cell death,damaged,disintegrate,disintegration
View More

Try a synonym, or sign up to request an icon from the app.

Image types

Endothelial cell 1 (dying 2) icon JPEG

Endothelial cell 1 (dying 2) icon PNG

Endothelial cell 1 (dying 2) icon SVG

Endothelial cell 1 (dying 2) icon GIF

Biorender Icon FAQs

How are scientists using the Endothelial cell 1 (dying 2) icon in their work?

BioRender users often use the Endothelial cell 1 (dying 2) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

Can I use this icon in a BioRender figure or scientific illustration?

Yes, the Endothelial cell 1 (dying 2) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Endothelial cell 1 (dying 2) icon customizable in BioRender?

Most icons in BioRender, including the Endothelial cell 1 (dying 2) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Endothelial cell 1 (dying 2) icon for publication or presentations?

Yes, figures containing the Endothelial cell 1 (dying 2) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Endothelial cell 1 (dying 2) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Endothelial cell 1 (dying 2) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

What is BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Endothelial cell 1 (dying 2) icon along with our library of more than 30,000 life science icons.

Looking for science content?

Browse 50K+ icons and templates that are peer-reviewed, easy to use, and free.

Find yours now
x icon